Our History
Discover the history of GSK using our interactive timeline.
About GlaxoSmithKline Inc.
GlaxoSmithKline Inc. (GSK) is a world leading research-based pharmaceutical company devoted to discovering and developing new and innovative medicines and vaccines for Canadians and people around the world. Every day, our employees strive to improve the quality of human life by enabling people to do more, feel better and live longer.
Business Development
GSK in Canada’s Business Development Team identifies and evaluates opportunities, including the acquisition and in-licensing of new products and services, to expand and diversify the company’s portfolio.
If you are interested in partnering with us, please contact Sav DiPasquale, Vice President, Business Development at 905-819-3000.
Therapeutic Areas
GSK produces medicines for five major disease areas - respiratory illness, diabetes, virus control, infections and central nervous system disorders. In addition, we are a leader in the important area of vaccines and are developing new treatments for cancer. GlaxoSmithKline's medicines treat:
- Allergy
- Asthma
- Cancer
- Chronic obstructive pulmonary disease
- Depression
- Diabetes
- Epilepsy
- Gastrointestinal disorders
- Herpes
- HIV/AIDS
- Infectious diseases
- Migraine
The company is also Canada's leading flu vaccine manufacturer and supplies 75 per cent of Canadian government seasonal flu vaccine purchases.
A Caring Company
GSK is designated a Caring Company by Imagine Canada, contributing more than one per cent of pre-tax profits annually through The GlaxoSmithKline Foundation and other channels to initiatives in health, science education and local community organizations.
The Pathfinders Fund
The $22 million GlaxoSmithKline Pathfinders Fund for Leaders in Canadian Health Science Research was established to help Canada become a world leader in R&D. This initiative encourages health science research and fosters innovation in Canadian medical schools.
